Finance

Lists
WOCKPHARMA:NSE
Wockhardt Ltd
₹ १,९४८.२०
-१.९१%
(-३७.९०) 1D
अक्टोबर १५, ११:१९:४२ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
₹ १,९८८.००
High
₹ १,९८८.००
Low
₹ १,९४६.६०
Mkt. cap
३.१८ खरब
Avg. vol.
११.८५ लाख
Volume
१.५८ लाख
P/E ratio
७७.३९
52-wk high
₹ २,४२२.३०
52-wk low
₹ १,०८६.७०
EPS
₹ २५.१७
Shares outstanding
११.०७ करोड
No. of employees
३ हजार
Open
₹ १,९८८.००
High
₹ १,९८८.००
Low
₹ १,९४६.६०
Mkt. cap
३.१८ खरब
Avg. vol.
११.८५ लाख
Volume
१.५८ लाख
P/E ratio
७७.३९
52-wk high
₹ २,४२२.३०
52-wk low
₹ १,०८६.७०
EPS
₹ २५.१७
Shares outstanding
११.०७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
९ मिनेट पहिले
Dow (DOW) Draws Fresh Interest As Earnings Optimism Puts Valuation Back In Focus
MarketBeat
MarketBeat
·
८ मिनेट पहिले
Nasdaq (NDAQ) Projected to Release Quarterly Earnings on Thursday
Investor's Business Daily
Investor's Business Daily
·
२ घण्टा पहिले
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees२.५६ हजार
Founded१९६७
Headquarters-
Sector-
Last report
२०२६ अगस्ट १०
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
९.२९ अरब / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७.८२ अरब
८.८८ अरब
१०.५४ अरब
९.२९ अरब
Cost of goods sold
२.३३ अरब
३.१७ अरब
४.०३ अरब
३.२० अरब
Cost of revenue
२.३३ अरब
३.१७ अरब
४.०३ अरब
३.२० अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.८६ अरब
१.८१ अरब
१.९० अरब
२.०३ अरब
Operating expense
४.४२ अरब
४.६३ अरब
४.१९ अरब
४.७६ अरब
Total operating expenses
६.७५ अरब
७.८० अरब
८.२२ अरब
७.९६ अरब
Operating income
१.०७ अरब
१.०८ अरब
२.३२ अरब
१.३३ अरब
Other non operating income
२१.०० करोड
२५.०० करोड
-७१.०० करोड
३१.०० करोड
EBT including unusual items
९१.०० करोड
६७.०० करोड
१.८९ अरब
१.१६ अरब
EBT excluding unusual items
९१.०० करोड
७७.०० करोड
१.५२ अरब
१.१६ अरब
Income tax expense
९.०० करोड
६.०० करोड
२५.०० करोड
९.०० करोड
Effective tax rate
९.८९%
८.९६%
१३.२३%
७.७६%
Other operating expenses
२.०३ अरब
२.१७ अरब
१.७६ अरब
२.१८ अरब
Net income
७८.०० करोड
५९.०० करोड
१.६६ अरब
१.०६ अरब
Net profit margin
९.९७%
६.६४%
१५.७५%
११.४१%
Earnings per share
-
-
-
-
Interest and investment income
-
-
७.०० करोड
-
Interest expense
-५५.०० करोड
-६०.०० करोड
-४५.०० करोड
-५२.०० करोड
Net interest expenses
-५५.०० करोड
-६०.०० करोड
-३८.०० करोड
-५२.०० करोड
Depreciation and amortization charges
५३.०० करोड
६५.०० करोड
५३.०० करोड
५५.०० करोड
EBITDA
१.६२ अरब
१.४७ अरब
२.७४ अरब
१.७४ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू